An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00214812 |
Recruitment Status
: Unknown
Verified September 2005 by Biosyn.
Recruitment status was: Recruiting
First Posted
: September 22, 2005
Last Update Posted
: October 25, 2005
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
HIV Infections | Drug: HEC placebo gel | Phase 1 |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 6 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Double |
Primary Purpose: | Treatment |
Official Title: | An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots |
Study Start Date : | June 2005 |
- Presence or absence of bare spots with and without Gd.
- Quantification and location of bare spots.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 45 Years (Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 18 -45 year old women
- normal Pap smear
- not pregnant
Exclusion Criteria:
- abnormal pelvic exam
- history of claustrophobia
- allergy to product formulation
- pregnant or breastfeeding

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00214812
Contact: Kurt Barnhart, MD | 215 662 2974 |
United States, Pennsylvania | |
Reproductive Research Unit, U of Penn Medical Center | Recruiting |
Philadelphia, Pennsylvania, United States, 19104 | |
Contact: Kurt Barnhart, MD 215-662-2974 |
Principal Investigator: | Kurt Barnhart, MD | University of Pennsylvania |
ClinicalTrials.gov Identifier: | NCT00214812 History of Changes |
Other Study ID Numbers: |
RRU-005 |
First Posted: | September 22, 2005 Key Record Dates |
Last Update Posted: | October 25, 2005 |
Last Verified: | September 2005 |
Keywords provided by Biosyn:
HIV Seronegativity HIV |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |